Kuwait Migraine Drugs Market Size & Outlook, 2023-2030
The migraine drugs market in Kuwait is expected to reach a projected revenue of US$ 63.4 million by 2030. A compound annual growth rate of 14.2% is expected of Kuwait migraine drugs market from 2024 to 2030.
Revenue, 2023 (US$M)
$25.0
Forecast, 2030 (US$M)
$63.4
CAGR, 2024 - 2030
14.2%
Report Coverage
Kuwait
Kuwait migraine drugs market, 2018-2030 (US$M)
Related Markets
Kuwait migraine drugs market highlights
- The Kuwait migraine drugs market generated a revenue of USD 25.0 million in 2023 and is expected to reach USD 63.4 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 14.2% from 2024 to 2030.
- In terms of segment, acute was the largest revenue generating treatment in 2023.
- Preventive is the most lucrative treatment segment registering the fastest growth during the forecast period.
Migraine drugs market data book summary
| Market revenue in 2023 | USD 25.0 million |
| Market revenue in 2030 | USD 63.4 million |
| Growth rate | 14.2% (CAGR from 2023 to 2030) |
| Largest segment | Acute |
| Fastest growing segment | Preventive |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Acute, Preventive |
| Key market players worldwide | GlaxoSmithKline, Pfizer Inc, AbbVie Inc, Amgen Inc, Eli Lilly and Co, Teva Pharmaceutical Industries Ltd, Biohaven Ltd, Johnson & Johnson, Bausch Health Companies Inc |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.4% of the global migraine drugs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia migraine drugs market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 73.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Migraine Drugs Market Scope
Migraine drugs market segmentation & scope
Triptans
Acetylcholine inhibitors/ neurotoxins
Ergot alkaloids
NSAIDs
Ditans
CGRP small molecule antagonists
CGRP monoclonal antibodies
Others
Migraine Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Kuwait migraine drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to migraine drugs market will help companies and investors design strategic landscapes.
Acute was the largest segment with a revenue share of 63.6% in 2023. Horizon Databook has segmented the Kuwait migraine drugs market based on acute, preventive covering the revenue growth of each sub-segment from 2018 to 2030.
- Kuwait Migraine Drugs Treatment Outlook (Revenue, USD Million, 2018-2030)
- Acute
- Preventive
- Kuwait Migraine Drugs Therapeutic Class Outlook (Revenue, USD Million, 2018-2030)
- Triptans
- Acetylcholine inhibitors/ neurotoxins
- Ergot alkaloids
- NSAIDs
- Ditans
- CGRP small molecule antagonists
- CGRP monoclonal antibodies
- Others
- Kuwait Migraine Drugs Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral
- Injectable
- Others
- Kuwait Migraine Drugs Age Group Outlook (Revenue, USD Million, 2018-2030)
- Pediatric
- Adult
- Geriatric
- Kuwait Migraine Drugs Availability Outlook (Revenue, USD Million, 2018-2030)
- Prescription Drugs
- Over-the-Counter (OTC) Drugs
Reasons to subscribe to Kuwait migraine drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Kuwait migraine drugs market databook
-
Our clientele includes a mix of migraine drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait migraine drugs market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait migraine drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Kuwait migraine drugs market size, by treatment, 2018-2030 (US$M)
Kuwait Migraine Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
